C

Checkmate Capital Group, LLC.

8 employees

Checkmate Capital is an investment and transaction advisory group with a global investor network that manages family office assets.

Investor insights

Sectors invested in

Biotechnology4
Pharmaceutical3
Leukemia1
Personalized Medicine1
Biomarker Discovery1
Drug Discovery1
Hematological Malignancies1
Companion Diagnostics1
Multiple Myeloma1
Health Care1
Plastic Surgery1
biotechnology1
Medical Device1
Life Science1
General Surgery1
Oil and Gas1
Small Molecule1
Research1
Oncology1
Telomere Targeting1

Funding rounds participated in

$5M sweet spot round size

Most of their 8 investments are in rounds between $1M and $8M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services

Date founded

2017

Investments made

U

Undisclosed raised undisclosed on May 19, 2023

Investors: Checkmate Capital Group, LLC.

L

Lynx Biosciences (LynxBio) raised undisclosed on November 3, 2021

Investors: Wisconsin Investment Partners, Cove Fund and Checkmate Capital Group, LLC.

M

MAIA Biotechnology, Inc. raised $8M on May 19, 2021

Investors: SSIF Broker and Checkmate Capital Group, LLC.

U

Undisclosed raised $10M on May 10, 2021

Investors: Angel Physicians Fund, BlueStone Venture Partners, Bioverge, MedTex Ventures, Global Health Impact Fund, Wolverine Venture Fund, IAG Capital Partners, Willamette Valley Capital, Sand Hill Angels and Checkmate Capital Group, LLC.

L

Lactiga raised $1.4M on December 1, 2020

Investors: 1517 Fund and Checkmate Capital Group, LLC.

U

Undisclosed raised $1M on April 8, 2020

Investors: Checkmate Capital Group, LLC.

S

Site Fuel, Inc. raised $5M on April 25, 2018

Investors: Checkmate Capital Group, LLC.

T

TELA Bio raised undisclosed on April 16, 2018

Investors: Checkmate Capital Group, LLC.

FAQ